HRT Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,218	Closed	-$2.02M	–	4462
2025 Q4	$2.46M	Buy	+4,218	New	+$2.15M	0.01%	1176
2025 Q1	–	Sell	-12,588	Closed	-$3.88M	–	3061
2024 Q4	$3.88M	Buy	12,588 +2,500	+25%	+$703K	0.02%	476
2024 Q3	$2.14M	Buy	+10,088	New	+$2.58M	0.01%	860
2024 Q1	–	Sell	-3,716	Closed	-$859K	–	2794
2023 Q4	$859K	Buy	+3,716	New	+$650K	0.01%	1068
2023 Q2	–	Sell	-13,270	Closed	-$3.21M	–	2957
2023 Q1	$3.21M	Buy	13,270 +2,351	+22%	+$641K	0.04%	408
2022 Q4	$3.17M	Buy	+10,919	New	+$1.07M	0.05%	403
2022 Q1	–	Sell	-9,589	Closed	-$812K	–	3581
2021 Q4	$812K	Buy	+9,589	New	+$788K	﹤0.01%	1301
2021 Q3	–	Sell	-10,759	Closed	-$1.05M	–	3604
2021 Q2	$1.05M	Buy	+10,759	New	+$1.27M	0.01%	1020
2020 Q4	–	Sell	-7,019	Closed	-$833K	–	2216
2020 Q3	$833K	Buy	+7,019	New	+$762K	0.03%	656
2019 Q4	–	Sell	-4,217	Closed	-$363K	–	1464
2019 Q3	$363K	Buy	+4,217	New	+$396K	0.02%	831